Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MEBO Anti Itch is a topical natural ointment developed by MEBO Group to soothe irritated skin and reduce the urge to scratch. Formulated with botanical extracts and natural ingredients, including cactus extract (*Opuntia dillenii* juice), sesame oil, Radix scutellariae, and beeswax, it provides a regenerative environment that supports the natural repair of cracked, chafed, or dry scaly skin. The ointment is designed to protect and repair nerve endings in skin tissue and promote epithelial repair through stem cell regeneration. It is registered as a cosmetic in China and other select countries, and is suitable for soothing itchiness associated with insect bites, chicken pox, eczema, and dermatitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MEBO Anti Itch.